BioAge Labs Inc [BIOA] stock prices are up 13.88% to $10.5 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BIOA shares have gain 12.30% over the last week, with a monthly amount glided 40.56%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
BioAge Labs Inc [NASDAQ: BIOA] stock has seen the most recent analyst activity on October 22, 2025, when Citigroup upgraded its rating to a Buy but kept the price target unchanged to $10 for it. On December 10, 2024, downgrade downgraded it’s rating to Underweight and revised its price target to $5 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $7 on December 09, 2024. Citigroup downgraded its rating to a Neutral and reduced its price target to $7 on December 09, 2024. Morgan Stanley started tracking with an Overweight rating for this stock on October 21, 2024, and assigned it a price target of $40. In a note dated October 21, 2024, Jefferies initiated a Buy rating and provided a target price of $42 on this stock.
The stock price of BioAge Labs Inc [BIOA] has been fluctuating between $2.88 and $20.37 over the past year. Currently, Wall Street analysts expect the stock to reach $19 within the next 12 months. BioAge Labs Inc [NASDAQ: BIOA] shares were valued at $10.5 at the most recent close of the market. An investor can expect a potential return of 80.95% based on the average BIOA price forecast.
Analyzing the BIOA fundamentals
Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -15.16%, Pretax Profit Margin comes in at -12.81%, and Net Profit Margin reading is -12.81%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.25 and Total Capital is -0.32. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.88 points at the first support level, and at 9.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.08, and for the 2nd resistance point, it is at 11.67.
Ratios To Look Out For
It’s worth pointing out that BioAge Labs Inc [NASDAQ:BIOA]’s Current Ratio is 11.87. Further, the Quick Ratio stands at 11.87, while the Cash Ratio is 8.8. Considering the valuation of this stock, the price to sales ratio is 63.59, the price to book ratio is 1.36.
Transactions by insiders
Recent insider trading involved RUBIN PAUL D, Officer, that happened on Dec 04 ’25 when 68897.0 shares were purchased.
